Divestments

Divestments are an important part of any corporate company's growth strategy and require the same skill of execution — and dedication to the process — as any other transaction. With a strong track record in company divestitures, undertaken for a multitude of international corporates, we can help you realign your portfolio and redeploy capital to the growth of your core business.

With our experienced team, sector insights and buyer access, we can deliver a transaction at the optimal deal terms and structure.

Divestments Deals

May 2021
has formed a strategic alliance with
Jan 2021
has divested its Mirabel manufacturing site in Riom, France to
Jan 2021
has divested its Ringaskiddy analytics and testing site to
Nov 2020
a division of QinetiQ
has been acquired by
a division of Constellation Software
Oct 2020
a Calculus Capital-backed company
has divested its mainframe RPA and terminal-emulation products to
a Bain Capital-backed company
Oct 2020
has divested its Poznań, Poland manufacturing site to
Sep 2020
has divested its Barcelona manufacturing sites to
Sep 2020
has divested its Segré, France manufacturing facility to
Jun 2020
a division of QinetiQ
has been acquired by
a TA Associates-backed company
Mar 2020
has divested its Mississauga, Ontario manufacturing facility to

Results. Great people creating great outcomes, together.

Latest Insights

Reports
21st July 2021

Marketing Services: Global M&A and Public Company Performance H1 2021

We are pleased to share with you the H1 2021 Marketing Services Sector Review, where we analyse global M&A activity and public market performance in the marketing services sector. We continue to see very good levels of deal activity in the Marketing Services sector with H1 2021 deal volume up by 22% on H1 2020 […]

Reports
19th July 2021

The Global Technology Market Review – Q2 2021

As we predicted in Q1, deal activity has continued to increase in Q2 and the technology market remains very strong for M&A and public trading and optimism for future growth remains very healthy across all the technology sectors we track. M&A continues to be driven by strong levels of investment by private equity (directly and […]

Insights
17th May 2021

The next chapter: Changing market dynamics in commercialisation and medical communications

The last twelve months have been a time of extraordinary activity in the commercialisation sector – the COVID-19 pandemic saw medcomms groups play a crucial part in keeping pharma companies connected with patients and healthcare professionals, and dealmaking was frenetic on both sides of the Atlantic, for smaller agencies as well as for emerging ‘CCOs’. […]